Literature DB >> 32476939

A case of relapsing isolated neurosarcoidosis in an 18-year-old male patient successfully treated by corticosteroids.

Klaudia Kalmárová1, Egon Kurča1, Štefan Sivák1, Jozef Michalik1, Lukáš Plank2, Robert Vyšehradský3, Kamil Zeleňák4, Juraj Šutovský5, Vladimír Nosáľ1.   

Abstract

Sarcoidosis is a granulomatous multisystemic disease of unknown cause most often affecting the lungs, lymph nodes of the pulmonary hilus, eyes, skin, and other structures including central (CNS) or peripheral nervous system (PNS). Isolated neurosarcoidosis is extremely rare. The diagnosis of isolated neurosarcoidosis is challenging because of its rarity, variety of manifestations, and the lack of systemic signs. We report relapsing and remitting isolated intracranial neurosarcoidosis in an 18-year-old male patient who undervent complex diagnostics including cerebral and meninges biopsy. Patient was succesfully treated with corticosteroids. Copyright:
© 2019.

Entities:  

Keywords:  biopsy; isolated neurosarcoidosis; treatment

Mesh:

Substances:

Year:  2019        PMID: 32476939      PMCID: PMC7247112          DOI: 10.36141/svdld.v36i1.7168

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  14 in total

Review 1.  Neurosarcoidosis: a review of its intracranial manifestation.

Authors:  D A Nowak; D C Widenka
Journal:  J Neurol       Date:  2001-05       Impact factor: 4.849

Review 2.  Imaging manifestations of neurosarcoidosis.

Authors:  J Keith Smith; Maria Gisele Matheus; Mauricio Castillo
Journal:  AJR Am J Roentgenol       Date:  2004-02       Impact factor: 3.959

3.  Cranial base manifestations of neurosarcoidosis: a review of 305 patients.

Authors:  Matthew L Carlson; James R White; Mana Espahbodi; David S Haynes; Colin L W Driscoll; Allen J Aksamit; Siddharama Pawate; John I Lane; Michael J Link
Journal:  Otol Neurotol       Date:  2015-01       Impact factor: 2.311

4.  Long-term follow-up of vanishing tumors in the brain: how should a lesion mimicking primary CNS lymphoma be managed?

Authors:  Yoshiko Okita; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Shintaro Fukushima; Akiko Maeshima; Takamasa Kayama; Soichiro Shibui
Journal:  Clin Neurol Neurosurg       Date:  2012-03-22       Impact factor: 1.876

5.  Clinically isolated neurosarcoidosis: a recommended diagnostic path.

Authors:  Susanne Wegener; Michael Linnebank; Roland Martin; Anton Valavanis; Michael Weller
Journal:  Eur Neurol       Date:  2014-11-12       Impact factor: 1.710

6.  Isolated neurosarcoidosis: case series in 2 sarcoidosis centers.

Authors:  Kenkichi Nozaki; Thomas F Scott; Mimi Sohn; Marc A Judson
Journal:  Neurologist       Date:  2012-11       Impact factor: 1.398

7.  Isolated neurosarcoidosis presenting with multiple cranial nerve palsies.

Authors:  Kiyoharu Shimizu; Kiyoshi Yuki; Takashi Sadatomo; Kaoru Kurisu
Journal:  Surg Neurol Int       Date:  2016-04-19

8.  Neurosarcoidosis in a Tertiary Referral Center: A Cross-Sectional Cohort Study.

Authors:  Sonja E Leonhard; Daan Fritz; Filip Eftimov; Anneke J van der Kooi; Diederik van de Beek; Matthijs C Brouwer
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 9.  Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis.

Authors:  Daan Fritz; Diederik van de Beek; Matthijs C Brouwer
Journal:  BMC Neurol       Date:  2016-11-15       Impact factor: 2.474

10.  A Rare Case of Isolated Cerebral Sarcoidosis Presenting as Suprasellar Mass Lesion with Salt-Wasting Hypopituitarism.

Authors:  H Krenzlin; D Jussen; C Musahl; S Scheil-Bertram; K Wernecke; P Horn
Journal:  J Neurol Surg Rep       Date:  2015-04-27
View more
  2 in total

1.  Asymptomatic tiny subcutaneous eruptions in a patient with sarcoid neuropathy: the effectiveness of fluorine-18 fluorodeoxyglucose positron emission tomography for targeting safe biopsy sites.

Authors:  Makoto Kobayashi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

2.  Pituitary Sarcoidosis in a Pediatric Patient Successfully Treated With Adalimumab and Methotrexate.

Authors:  D Sofia Villacis-Nunez; Amit Thakral
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.